[Form 4] PubMatic, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Rajeev K. Goel, PubMatic, Inc. CEO, director and 10% owner, reported multiple transactions on 09/15/2025. He exercised 44,000 stock options with an exercise price of $1.11 and reports options that are fully vested and expire on 07/07/2026. On the same date, 44,000 shares were transferred to The Goel Family Trust and sold under a Rule 10b5-1 trading plan at a weighted average price of $8.2243 (range $8.145–$8.37). Following these transactions, Mr. Goel beneficially owns 2,362,194 shares of Class A and Class B common stock, excluding unvested awards.
Positive
- Options fully vested and exercised (44,000 shares) with explicit expiration date 07/07/2026
- Detailed disclosure of sales price range ($8.145–$8.37) and weighted average sale price ($8.2243)
- Continued substantial ownership: 2,362,194 beneficially owned shares following the transactions
Negative
- Disposition of 44,000 shares sold by The Goel Family Trust on 09/15/2025
- Potential dilution detail present (multiple option and trust-held share lines) requiring further aggregation to assess full dilution impact
Insights
TL;DR: Insider exercised vested options and a related trust sold 44,000 shares at ~$8.22; overall ownership remains >2.3M shares.
The filing shows an option exercise at $1.11 for 44,000 shares that were converted/treated across Class B/A share classes and an immediate disposition of 44,000 shares through The Goel Family Trust under a Rule 10b5-1 plan at a weighted average price of $8.2243. The option award expires 07/07/2026 and is fully vested. After reported activity, Mr. Goel reports 2,362,194 beneficially owned shares, not counting unvested awards. For valuation or dilution analysis, analysts should incorporate the remaining in-the-money options and conversion mechanics disclosed here.
TL;DR: Transactions are routine insider exercise and programmed sale via 10b5-1; significant beneficial ownership retained.
The report discloses standard Section 16 transactions: an exercised option and coordinated sale by a family trust pursuant to a Rule 10b5-1 trading plan adopted March 2, 2025. Footnotes clarify holdings held in various trusts and custodial arrangements with disclaimed beneficial ownership for certain trust-held shares. The disclosure includes exercisability, expiration date of the options, and the price range for shares sold, providing transparency on timing and structure of the transactions.